VLA
Click for more information
0.00% $1.75 viralytics limited

Abstract CT114 withheld due to inclusion in official press program

  1. BoronP
    1,076 Posts.
    lightbulb Created with Sketch. 122
    clock Created with Sketch.
    01/04/17
    07:29
    Post #: 23785614
    CT114 - The MITCI (Phase 1b) study: A novel immunotherapy combination of intralesional Coxsackievirus A21 and systemic ipilimumab in advanced melanoma patients with or without previous immune checkpoint therapy treatment

    CT114: "This abstract has been withheld from publication due to its inclusion in the AACR Annual Meeting 2017 Official Press Program. It will be posted online following its presentation."

    http://www.abstractsonline.com/pp8/#!/4292/presentation/12329

    I can only assume this indicates exceptional results?
    VLA Price at posting: $1.20 Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 22  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

ARU Cashed up Arafura locks in $171M German export agency deal; locks in NdPr offtake for wind turbines
right-arrow Created with Sketch.
RZI https://hotcopper.com.au/news/asx-news/149063/fast-track-assaying-yields-182-g-t-gold-for-itech-at-new-nt-play/
right-arrow Created with Sketch.
NEWS Finding properties tenants will want to rent
right-arrow Created with Sketch.
STN Saturn’s stars have aligned for the gold explorer’s Apollo Project
right-arrow Created with Sketch.
AWJ Auric jumps 10% on maiden cash sales in Q3CY24 and firm guidance
right-arrow Created with Sketch.
SXE SCEE boosts Synergy deal by $50M for Collie battery project
right-arrow Created with Sketch.
watchlist Created with Sketch. Add VLA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.